Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3) Peptid
RARRES3
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN982668
150,78 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 15 bis 22 Werktagen
Kurzübersicht für Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3) Peptid (ABIN982668)
Target
RARRES3
(Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-RARRES3 antibody (Catalog #: ARP46474_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Aufreinigung
- Purified
-
-
-
-
Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Konzentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- RARRES3 (Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3))
-
Hintergrund
-
Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES3 is thought act as a tumor suppressor or growth regulator.Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator.
Alias Symbols: HRASLS4, MGC8906, RIG1, TIG3, PLA1/2-3
Protein Interaction Partner: TGM1,HRAS,TGM1,RNF135,TRIM25
Protein Size: 164 -
Molekulargewicht
- 18 kDa
-
Gen-ID
- 5920
-
NCBI Accession
- NM_004585, NP_004576
-
UniProt
- Q9UL19
Target
-
Sie sind hier:
